ImCheck Therapeutics

Become the referent of this startup

ImCheck Therapeutics develops a new generation of immunotherapy antibodies positioned at the crossroads of two high-potential immunological fields: γ9δ2 T cells and a novel super-family of immunomodulators, butyrophilins.
Automatic translation

Technologies

  • REDBIOTECH
  • BIOENGINEERING
  • DNA
  • DEEPTECH

Activity area

  • HEALTHTECH
  • PHARMATECH
  • CLINIC
  • ONCOLOGY
  • BIOTECH
  • IMMUNOLOGY

Maturity stage

  • Mature

http://www.imchecktherapeutics.com/

Key information

Year of creation

2015

Workforce

11 - 50

Maturity stage

Mature

Total fundraising amount

170 000 000 €

Last round table level

Investment

Total fundraising amount

170 000 000 €

Maximum round table reached

Date Amount Investors Round table
01/03/2017 20 000 000,00 €
05/12/2019 48 000 000,00 €
01/10/2020 6 000 000,00 €
01/07/2022 96 000 000,00 €

Similar start-ups